AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Arrowhead PharmaceuticalsZai LabPTC TherapeuticsFibroGenEmergent Biosolutions
SymbolNASDAQ:ARWRNASDAQ:ZLABNASDAQ:PTCTNASDAQ:FGENNYSE:EBS
Price Information
Current Price$32.77$74.01$50.95$33.65$89.30
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.61.11.31.71.4
Analysis Score4.41.53.34.32.4
Community Score2.52.32.52.52.7
Dividend Score0.00.00.00.00.0
Ownership Score1.01.00.01.01.0
Earnings & Valuation Score0.00.60.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$62.00$57.31$62.83$57.60$83.86
% Upside from Price Target89.20% upside-22.57% downside23.32% upside71.17% upside-6.10% downside
Trade Information
Market Cap$3.28 billion$4.24 billion$3.19 billion$3.00 billion$4.38 billion
Beta1.761.111.451.481.27
Average Volume1,572,434477,953869,218680,658485,040
Sales & Book Value
Annual Revenue$168.80 million$12.98 million$306.98 million$256.58 million$1.11 billion
Price / Sales19.76331.3110.4411.694.23
Cashflow$0.79 per shareN/AN/AN/A$5.51 per share
Price / Cash41.60N/AN/AN/A16.20
Book Value$2.57 per share$5.07 per share$9.64 per share$6.14 per share$21.08 per share
Price / Book12.7514.605.295.484.24
Profitability
Net Income$67.97 million$-195,070,000.00$-251,580,000.00$-76,970,000.00$54.50 million
EPS$0.69($3.03)($3.45)($0.89)$2.91
Trailing P/E Ratio364.15N/AN/AN/A68.69
Forward P/E RatioN/AN/AN/AN/A26.66
P/E GrowthN/AN/AN/AN/AN/A
Net Margins6.86%N/A-90.83%-42.75%6.15%
Return on Equity (ROE)2.61%N/A-46.42%-19.32%14.58%
Return on Assets (ROA)2.08%N/A-17.31%-12.59%6.59%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%N/A0.56%0.07%0.71%
Current Ratio5.90%6.27%3.18%11.14%3.03%
Quick Ratio5.90%6.14%3.09%11.01%1.83%
Ownership Information
Institutional Ownership Percentage64.26%78.29%N/A71.66%85.61%
Insider Ownership Percentage4.00%N/A7.00%7.83%14.10%
Miscellaneous
Employees1163095114611,834
Shares Outstanding101.77 million58.11 million62.88 million89.11 million52.43 million
Next Earnings Date8/3/2020 (Estimated)N/A8/4/2020 (Estimated)8/13/2020 (Estimated)8/6/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.